Alectos Therapeutics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8999 Nelson Way, Burnaby, British Columb...Phone Number
(604) 628-7129Website
www.alectos.comRevenue
<$5 MillionIndustry
About Alectos Therapeutics
Alectos Therapeutics is a leader in the discovery and preclinical development of novel small-molecule therapeutics aimed at treating neurological diseases. The company focuses on innovative approaches to address complex conditions such as Alzheimer's disease, Parkinson's disease, and acute ischemic stroke. Their pipeline includes programs like GBA2, which targets lysosomal dysfunction, and OGA, which offers neuroprotective strategies. Alectos welcomes partnership inquiries regarding their advanced preclinical development candidates.Explore more
Alectos Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Alectos Therapeutics
Compare insights from companies similar to Alectos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alectos Therapeutics Tech Stack
A closer look at the technologies used by Alectos Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding Alectos Therapeutics
Sign Up For FreeTo access detailed company insights
Alectos Therapeutics is a leader in the discovery and preclinical development of novel small-molecule therapeutics aimed at treating neurological diseases. The company focuses on innovative approaches to address complex conditions such as Alzheimer's disease, Parkinson's disease, and acute ischemic stroke. Their pipeline includes programs like GBA2... Read More
